Aspect Biosystems

Aspect Biosystems is a biotechnology company pioneering bioprinted tissue therapeutics to transform how we treat some of the most elusive diseases. Its full-stack tissue therapeutic platform integrates proprietary AI-powered bioprinting technology, computational design tools, therapeutic cells and advanced biomaterials to create implantable tissues that can replace, repair or supplement biological functions.

Established
2013

Aligned investment theme
Elevating inclusive communities

Purpose
To transform how we treat the most elusive diseases

Year invested
2024